Contineum Therapeutics (CTNM) Stock Chart & Stock Price History $4.43 -0.20 (-4.32%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$4.42 0.00 (-0.11%) As of 06/13/2025 04:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Contineum Therapeutics Stock Price Performance The Contineum Therapeutics (CTNM) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 72.31%, with a year-to-date return of -69.76%. In the past month, the stock has increased 15.36%, reflecting recent market activity. As of the latest close, Contineum Therapeutics traded at $4.43 with a market cap of $114.61 million and volume of 145,157 shares. Receive CTNM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Contineum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.12%1 Month Performance+15.36%3 Month Performance-33.58%Year-To-Date Performance-69.76%1 Year Performance-72.31% CTNM Stock Chart for Saturday, June, 14, 2025 CTNM Chart by TradingView Contineum Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/13/2025$4.63$4.43-4.32%$4.62$4.18145,157 shs$114.61 million06/12/2025$4.57$4.63+1.31%$4.88$4.44115,375 shs$119.79 million06/11/2025$4.88$4.57-6.35%$4.97$4.46118,231 shs$118.24 million06/10/2025$4.48$4.88+8.93%$5.02$4.49103,482 shs$126.26 million06/09/2025$4.75$4.48-5.68%$4.80$4.4356,837 shs$115.91 million06/06/2025$4.15$4.75+14.46%$4.77$3.9867,719 shs$122.89 million06/05/2025$4.41$4.15-5.90%$4.42$4.1149,999 shs$107.37 million06/04/2025$4.74$4.41-6.96%$4.76$4.3987,052 shs$114.10 million06/03/2025$4.43$4.74+7.00%$4.76$4.16571,920 shs$122.63 million06/02/2025$3.62$4.43+22.38%$4.70$3.75154,936 shs$114.61 million Get the Latest News and Ratings for CTNM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Contineum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/30/2025$3.57$3.62+1.40%$3.69$3.4358,846 shs$93.66 million05/29/2025$3.40$3.57+5.00%$3.63$3.3581,122 shs$92.36 million05/28/2025$3.51$3.40-3.13%$3.61$3.35135,481 shs$87.97 million05/27/2025$3.57$3.51-1.68%$3.60$3.5172,428 shs$90.81 million05/26/2025$3.57$3.57$3.85$3.51106,097 shs$92.36 million05/23/2025$3.91$3.57-8.70%$3.85$3.51106,097 shs$92.36 million05/22/2025$3.86$3.91+1.30%$4.01$3.71131,651 shs$101.16 million05/21/2025$3.83$3.86+0.78%$4.11$3.6783,186 shs$99.87 million05/20/2025$4.37$3.83-12.36%$4.37$3.79158,264 shs$99.09 million05/19/2025$3.51$4.37+24.50%$4.40$3.43201,956 shs$113.06 million05/16/2025$3.94$3.51-10.91%$3.99$3.49126,687 shs$90.81 million05/15/2025$3.84$3.94+2.60%$4.09$3.6290,296 shs$101.94 million05/14/2025$3.81$3.84+0.79%$4.43$3.75118,999 shs$99.35 million05/13/2025$3.83$3.81-0.52%$3.94$3.7167,885 shs$98.57 million Related Companies DNA Stock Chart ATAI Stock Chart UPXI Stock Chart ERAS Stock Chart TNGX Stock Chart SEPN Stock Chart PGEN Stock Chart PRTC Stock Chart CMPS Stock Chart ORGO Stock Chart Receive CTNM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Contineum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CTNM) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s worst nightmareThe President’s tour of the Middle East… the deal for Ukraine’s mineral rights… Elon’s strange time in Washing...Porter & Company | SponsoredGet in stocks now - and get out on this dateGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Contineum Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Contineum Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
